Edition:
United Kingdom

Gensight Biologics SA (SIGHT.PA)

SIGHT.PA on Paris Stock Exchange

1.69EUR
12 Nov 2018
Change (% chg)

€-0.13 (-7.14%)
Prev Close
€1.82
Open
€1.80
Day's High
€1.82
Day's Low
€1.68
Volume
109,912
Avg. Vol
75,130
52-wk High
€7.68
52-wk Low
€1.34

Chart for

About

Gensight Biologics SA is a France-based company, which specializes in the clinical-stage biotechnology and development of novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The Company, through I ts integrated development platform, combines a gene therapy-based approach with... (more)

Overall

Beta: --
Market Cap(Mil.): €45.08
Shares Outstanding(Mil.): 24.77
Dividend: --
Yield (%): --

Financials

  SIGHT.PA Industry Sector
P/E (TTM): -- 81.01 29.57
EPS (TTM): -0.99 -- --
ROI: -43.80 -0.53 12.77
ROE: -46.27 -3.22 14.47

Earnings vs. Estimates